6533b820fe1ef96bd127a4ca
RESEARCH PRODUCT
Estimation of Values below the Limit of Detection of a Contemporary Sensitive Troponin I Assay Improves Diagnosis of Acute Myocardial Infarction
Stergios TzikasStergios TzikasChristoph BickelStefan BlankenbergSophia M. ReisKarl J. LacknerLars PalapiesBeatrice Von JeinsenJes-niels BoeckelStephan BaldusThomas MünzelAndreas M. ZeiherTanja ZellerTill Kellersubject
Malemedicine.medical_specialtyClinical BiochemistryMyocardial Infarctionmacromolecular substancesCohort StudiesLimit of DetectionInternal medicineTroponin ImedicineHumanscardiovascular diseasesMyocardial infarctionAgedAged 80 and overDetection limitbiologybusiness.industryTroponin IBiochemistry (medical)Area under the curveMiddle AgedPrognosismedicine.diseaseTroponinCensoring (statistics)SurgeryROC CurveArea Under CurveAcute DiseaseCohortcardiovascular systemCardiologybiology.proteinRegression AnalysisFemaleMyocardial infarction diagnosisbusinessdescription
Abstract BACKGROUND The limit of detection (LoD) is the minimal amount of a substance that can be consistently detected. In the diagnosis of acute myocardial infarction (AMI) many patients present with troponin concentrations below the LoD of contemporary sensitive cardiac troponin I (cs-cTnI) assays. These censored values below the LoD influence the diagnostic performance of these assays compared to highly sensitive cTnI (hs-cTnI) assays. Therefore we assessed the impact of a new approach for interpolation of the left-censored data of a cs-cTnI assay in the evaluation of patients with suspected AMI. METHODS Our posthoc analysis used a real world cohort of 1818 patients with suspected MI. Data on cs-cTnI was available in 1786 patients. As a comparator the hs-cTnI version of the assay was used. To reconstruct quantities below the LoD of the cs-cTnI assay, a gamma regression approach incorporating the GRACE (Global Registry of Acute Coronary Events) score variables was used. RESULTS Censoring of cs-cTnI data below the LoD yielded weaker diagnostic information [area under the curve (AUC), 0.781; 95% CI, 0.731–0.831] regarding AMI compared to the hs-cTnI assay (AUC, 0.949; CI, 0.936–0.961). Use of our model to estimate cs-cTnI values below the LoD showed an AUC improvement to 0.921 (CI, 0.902–0.940). The cs-cTnI LoD concentration had a negative predictive value (NPV) of 0.950. An estimated concentration that was to be undercut by 25% of patients presenting with suspected AMI was associated with an improvement of the NPV to 0.979. CONCLUSIONS Estimation of values below the LoD of a cs-cTnI assay with this new approach improves the diagnostic performance in evaluation of patients with suspected AMI.
year | journal | country | edition | language |
---|---|---|---|---|
2015-02-06 | Clinical Chemistry |